Skin care formulation

Patent metadata

Field	Value
Publication number	US-9526689-B2
Application number	US-201213710097-A
Country	US
Kind code	B2
Filing date	Dec 10, 2012
Priority date	Dec 9, 2011
Publication date	Dec 27, 2016
Grant date	Dec 27, 2016

Abstract

Disclosed is a composition, and method for its use, that includes any one of, any combination of, or all of Centella asiactica, Vitis vinifera seed, Magnolia bark, Camellia sinensis , and/or dihydroxymethylchromone. The composition can be used to treat telangiectasia.

First claim

The invention claimed is:

1. A method of treating telangiectasia in a subject in need thereof comprising topically applying to skin of said subject in need of treatment of telangiectasia a composition comprising:
(a) an effective amount of an alcoholic extract of Centella asiactica leaf;
(b) an effective amount of an aqueous extract of Vitis vinifera seed;
(c) an effective amount of an alcoholic, hydro-alcoholic, or aqueous extract of Magnolia grandiflora bark;
(d) an effective amount of an alcoholic, hydro-alcoholic, or aqueous extract of Camellia sinensis leaf; and
(e) an effective amount of dihydroxymethylchromone,
wherein the Centella asiactica leaf and Vitis vinifera seed extracts disrupt endothelia tubes in skin.

2. The method of claim 1 , wherein the composition is applied to spider veins.

3. The method of claim 1 , wherein the composition remains on the skin for at least 5 minutes after topical application.

4. The method of claim 1 , wherein the telangiectasia is present on facial skin, leg skin, ankle skin, or arm skin.

5. The method of claim 1 , wherein the composition is a cream, gel, or lotion.

6. The method of claim 1 , wherein the composition is an emulsion.

7. The method of claim 1 , wherein the composition further comprises a moisturization agent, a UV absorbing agent, anti-oxidant, structuring agent, emulsifier, silicone containing compound, essential oil, thickening agent, and a preservative.

8. The method of claim 1 , wherein the composition further comprises Tambourissa trichophylla leaf extract.

9. The method of claim 1 , wherein the composition comprises:
0.01 to 1% by weight of the alcoholic extract of Centella asiatica leaf;
0.01 to 1% by weight of the aqueous extract of Vitis vinifera seed;
0.01 to 1% by weight of the alcoholic, hydro-alcoholic, or aqueous extract of Magnolia grandiflora bark;
0.01 to 1% by weight of the alcoholic, hydro-alcoholic, or aqueous extract of Camellia sinensis leaf; and
0.01 to 1% by weight of dihydroxymethylchromone.

10. The method of claim 1 , wherein the Magnolia grandiflora bark extract contains honokiol and magnolol, wherein the Centella asiatica leaf extract contains asiaticoside, madecassic acid, and asiatic acid, wherein the Camellia sinensis leaf extract contains epigallocatechin gallate, and wherein the Vitis vinifera seed extract contains polyphenols.

Assignees

• Mary Kay Inc

Inventors

• Florence Tiffany

Classifications

• A61K31/704

  attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin {(digitoxin A61K31/7048)} · CPC title

• A61P17/00

  Drugs for dermatological disorders · CPC title

• A61K31/56

  Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids · CPC title

• A61K36/82

  Theaceae (Tea family), e.g. camellia · CPC title

• A61K36/575

  Magnolia · CPC title